NZ221574A - Freeze-dried pharmaceutical compositions - Google Patents

Freeze-dried pharmaceutical compositions

Info

Publication number
NZ221574A
NZ221574A NZ221574A NZ22157487A NZ221574A NZ 221574 A NZ221574 A NZ 221574A NZ 221574 A NZ221574 A NZ 221574A NZ 22157487 A NZ22157487 A NZ 22157487A NZ 221574 A NZ221574 A NZ 221574A
Authority
NZ
New Zealand
Prior art keywords
freeze
pharmaceutical compositions
dried pharmaceutical
dried
compositions
Prior art date
Application number
NZ221574A
Other languages
English (en)
Inventor
Wu Chien-Chin
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of NZ221574A publication Critical patent/NZ221574A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ221574A 1986-08-28 1987-08-26 Freeze-dried pharmaceutical compositions NZ221574A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90125486A 1986-08-28 1986-08-28
US07/060,203 US4889862A (en) 1986-08-28 1987-06-10 Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids

Publications (1)

Publication Number Publication Date
NZ221574A true NZ221574A (en) 1989-11-28

Family

ID=26739681

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ221574A NZ221574A (en) 1986-08-28 1987-08-26 Freeze-dried pharmaceutical compositions

Country Status (17)

Country Link
US (1) US4889862A (enExample)
EP (1) EP0261426B1 (enExample)
JP (1) JP2629005B2 (enExample)
KR (1) KR950006218B1 (enExample)
AU (1) AU602715B2 (enExample)
CA (1) CA1312824C (enExample)
DE (1) DE3782480T2 (enExample)
DK (1) DK168655B1 (enExample)
ES (1) ES2052530T3 (enExample)
FI (1) FI90824C (enExample)
GR (1) GR3006608T3 (enExample)
HU (1) HU199289B (enExample)
IE (1) IE60490B1 (enExample)
IL (1) IL83662A (enExample)
NO (1) NO873626L (enExample)
NZ (1) NZ221574A (enExample)
PT (1) PT85612B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861783A (en) * 1988-04-26 1989-08-29 E. I. Du Pont De Nemours And Company 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
HU206975B (en) * 1991-03-14 1993-03-01 Reanal Finomvegyszergyar Process for producing granulation and veterinary composition comprising water-soluble flumequine complex
US6417167B1 (en) 1997-02-05 2002-07-09 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing shingoglycolipid and process for preparing them
AU739673B2 (en) * 1997-02-05 2001-10-18 Kirin Pharma Kabushiki Kaisha Lyophilized compositions containing sphingoglycolipid and process for preparing them
TWI232102B (en) * 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
US20060008529A1 (en) * 2004-07-12 2006-01-12 Meyerhoff Mark E Use of additive sites to control nitric oxide release from nitric oxide donors contained within polymers
WO2007005758A2 (en) * 2005-06-30 2007-01-11 Mc3, Inc. Methods , compositions and devices for promoting angiogenesis
CN101378792A (zh) * 2005-12-02 2009-03-04 密执安大学评议会 聚合物组合物、涂层和装置及其制备和使用方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US468299A (en) * 1892-02-02 John atkinson
DE433646C (de) * 1923-09-15 1926-09-09 Chem Fab Vorm E Schering Verfahren zur Herstellung in Wasser leicht loeslicher Derivate von Carbonsaeuren derChinolin- und Pyridinreihe
US3681495A (en) * 1969-08-25 1972-08-01 American Home Prod Freeze dried echothiophate iodide compositions
JPS5071816A (enExample) * 1973-11-02 1975-06-14
US4036954A (en) * 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
AT356278B (de) * 1976-07-12 1980-04-25 Hoffmann La Roche Verfahren zur herstellung von injektions- loesungen
JPS5976017A (ja) * 1983-01-20 1984-04-28 Yamanouchi Pharmaceut Co Ltd 安定なプロスタグランジンｅ類製剤の製法
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
DE3483704D1 (de) * 1983-07-22 1991-01-17 Du Pont Phenylchinolinsaeure und derivate als antitumormittel.
DE3329952A1 (de) * 1983-08-19 1985-02-28 Behringwerke Ag, 3550 Marburg Verfahren zur verringerung einer truebung in kontrollseren
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs

Also Published As

Publication number Publication date
NO873626D0 (no) 1987-08-27
KR950006218B1 (ko) 1995-06-12
FI873701L (fi) 1988-02-29
CA1312824C (en) 1993-01-19
KR880002507A (ko) 1988-05-09
AU602715B2 (en) 1990-10-25
DE3782480T2 (de) 1993-04-08
EP0261426A1 (en) 1988-03-30
AU7762287A (en) 1988-03-03
IE872290L (en) 1988-02-28
EP0261426B1 (en) 1992-11-04
DK168655B1 (da) 1994-05-16
NO873626L (no) 1988-02-29
PT85612B (pt) 1990-05-31
HU199289B (en) 1990-02-28
FI873701A0 (fi) 1987-08-26
US4889862A (en) 1989-12-26
IL83662A0 (en) 1988-01-31
FI90824C (fi) 1994-04-11
IE60490B1 (en) 1994-07-27
ES2052530T3 (es) 1994-07-16
GR3006608T3 (enExample) 1993-06-30
JP2629005B2 (ja) 1997-07-09
DE3782480D1 (de) 1992-12-10
IL83662A (en) 1991-09-16
DK447887D0 (da) 1987-08-27
PT85612A (en) 1987-09-01
JPS63115816A (ja) 1988-05-20
FI90824B (fi) 1993-12-31
HUT45398A (en) 1988-07-28
DK447887A (da) 1988-02-29

Similar Documents

Publication Publication Date Title
GB2196964B (en) Pharmaceutical compositions
GB8716301D0 (en) Pharmaceutical compositions
GB8717582D0 (en) Pharmaceutical compositions
GB8723121D0 (en) Pharmaceutical compositions
GB8714625D0 (en) Pharmaceutical compositions
GB8708587D0 (en) Pharmaceutical compositions
GB8717581D0 (en) Pharmaceutical compositions
GB2191696B (en) Pharmaceutical compositions
GB8618259D0 (en) Pharmaceutical compositions
GB2190838B (en) Pharmaceutical compositions
GB8728957D0 (en) Pharmaceutical compositions
GB8723120D0 (en) Pharmaceutical compositions
GB8723118D0 (en) Pharmaceutical compositions
IL83662A0 (en) Freeze-dried pharmaceutical compositions
GB2188235B (en) Pharmaceutical compositions
GB8719387D0 (en) Pharmaceutical compositions
GR871999B (en) Pharmaceutical compositions
GB8621756D0 (en) Pharmaceutical compositions
GB8615041D0 (en) Pharmaceutical compositions
ZA876446B (en) Freeze-dried pharmaceutical compositions
GB8618213D0 (en) Pharmaceutical compositions
GB8621085D0 (en) Pharmaceutical compositions
GB8612806D0 (en) Pharmaceutical compositions
GB8628476D0 (en) Pharmaceutical compositions
IE862120L (en) Pharmaceutical compositions